Published On: Mon, May 9th, 2016
Uncategorized | By Sylvia Delisle

Upgrades And Downgrades For Cambrex Corporation (NYSE:CBM)


Recently stock market analysts have updated their consensus ratings on shares of Cambrex Corporation (NYSE:CBM). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

02/11/2016 – Cambrex Corporation had its “buy” rating reiterated by analysts at Singular Research. They now have a USD 60 price target on the stock.

02/01/2016 – Sidoti began new coverage on Cambrex Corporation giving the company a “buy” rating. They now have a USD 60 price target on the stock.

07/31/2015 – Cambrex Corporation had its “buy” rating reiterated by analysts at Longbow Research. They now have a USD 60 price target on the stock.

07/21/2015 – Stephens began new coverage on Cambrex Corporation giving the company a “overweight” rating. They now have a USD 55 price target on the stock.

05/12/2015 – Cambrex Corporation was upgraded to “buy” by analysts at Zacks. They now have a USD 42 price target on the stock.

03/31/2015 – Craig-Hallum began new coverage on Cambrex Corporation giving the company a “buy” rating.

08/08/2014 – Cambrex Corporation was downgraded to “equal weight” by analysts at First Analysis.

02/14/2014 – Cambrex Corporation was upgraded to “hold” by analysts at Jefferson Research.

Cambrex Corporation has a 50 day moving average of 44.69 and a 200 day moving average of 44.17. The stock’s market capitalization is 1.54B, it has a 52-week low of 29.50 and a 52-week high of 55.60.

The share price of the company (NYSE:CBM) was down -0.80% during the last trading session, with a high of 48.99 and the volume of Cambrex Corporation shares traded was 409464.

View other investors thoughts on Cambrex Corporation on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.

Receive News & Ratings Via Email


Enter your email address below to get the latest news and analysts' ratings for your stocks with MarketBeat's FREE daily email newsletter:


Navigation